Immunotherapy Targeting Cancer Fusion Protein May Hold Key to Treating Rare Liver Cancer
St. Jude Children's Research HospitalResearchers from St. Jude Children’s Research Hospital and The University of Tennessee Health Sciences Center discovered two T-cell receptors in a single patient that recognizes the fusion and can guide T cells to kill all tumor cells carrying the hybrid protein in a mouse model.